PB Ratio: 3.24

Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/B ratio high or low?

The P/B ratio of 3.24 is 16% below its estimated 1-year average of 3.86, around the middle of its estimated 1-year range (1.39–6.25).

As of 2026-10-06T15:13:02.489Z. 26.50% below its estimated 12-month average of 4.41.

MAZE PB Ratio Metrics

P/B vs. estimated history

At 3.24, P/B is below its estimated 1-year median — higher than 30% of readings in its estimated 1-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Book Value Analysis

PB Ratio Formula & Definition

PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)

The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PB Ratio FAQ

What is the P/B ratio for Maze Therapeutics, Inc. (MAZE)?

The P/B ratio for MAZE stock is 3.24.

Is Maze Therapeutics, Inc.'s P/B ratio high or low?

The P/B ratio of 3.24 is 16% below its estimated 1-year average of 3.86, around the middle of its estimated 1-year range (1.39–6.25).

What is the estimated TTM average P/B ratio for Maze Therapeutics, Inc. (MAZE)?

The estimated TTM average P/B ratio for MAZE stock is 4.41.

Showing the most recent 260 of 349 data points. The chart above shows the full history.

Related Metrics